Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03088462 · ClinicalTrials.gov registry record · NA

LiveWell: A Mobile Intervention for Bipolar Disorder

A NA study of Bipolar Disorder and Bipolar I Disorder, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
205
Enrollment target
2
Study locations

NCT03088462 is a NA study of Bipolar Disorder and Bipolar I Disorder that has completed, run by Northwestern University. The registered enrollment target is 205 participants, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03088462, a NA study of Bipolar Disorder and Bipolar I Disorder, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
2
Study locations

Study Summary

LiveWell is a study evaluating the use of smartphones to better understand and improve the treatment of bipolar disorder. Our goal is to increase access to psychosocial interventions and improve their effectiveness in reducing symptoms and preventing mood episodes.

Interventions

  • BEHAVIORAL Psychosocial treatment
  • OTHER Psychiatric management
  • BEHAVIORAL LiveWell Program

Study Locations (2)

Illinois

  • Northwestern University - Chicago

Minnesota

  • HealthPartners Institute - Bloomington

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2017-03-20
Est. Completion 2021-04-10
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT03088462

The ClinicalTrials.gov registry entry for NCT03088462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (38% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 3 interventions - of which Psychosocial treatment is the first listed.

NCT03088462 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03088462 about?

NCT03088462 is a clinical study titled "LiveWell: A Mobile Intervention for Bipolar Disorder". LiveWell is a study evaluating the use of smartphones to better understand and improve the treatment of bipolar disorder. Our goal is to increase access to psychosocial interventions and improve their effectiveness in reducing symptoms and preventing mood episodes.

What is the current status of trial NCT03088462?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2017-03-20. Estimated completion is 2021-04-10.

What conditions does trial NCT03088462 study?

This clinical trial studies the following conditions: Bipolar Disorder, Bipolar I Disorder.

What interventions are being tested in trial NCT03088462?

The interventions under investigation include: Psychosocial treatment (BEHAVIORAL), Psychiatric management (OTHER), LiveWell Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03088462?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03088462 being conducted?

This trial has 2 study locations across Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.